Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Boston Scientific recalls premixed embolic agent after two deaths
There have been a total of 11 incidents so far, including seven injuries and two deaths. Boston Scientific said the agent can still be used if operators follow specific instructions during lower GI bleed embolization procedures.
Anemia may help explain why women are more likely to die during heart bypass surgery
Finding new ways to avoid intraoperative anemia could go a long way toward improving outcomes for female CABG patients. The full analysis, based on more than 1.4 million patients, was published in the Journal of the American College of Cardiology.
FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices
The anticoagulant was originally developed for patients with end-stage renal disease and atrial fibrillation.
FDA announces new recall of neurovascular catheters built by Johnson & Johnson subsidiary
The recall is due to ongoing concerns about the devices breaking. Three patients have been injured as a result of this issue.
GE Healthcare launching new AI software for handheld ultrasound system
The company's new AI offering, a product of its 2023 acquisition of Caption Health, will make its debut at ACC.24 in Atlanta.

Catheter-directed thrombolysis boosts survival rates for submassive pulmonary embolism

The new meta-analysis included data from nearly 10,000 patients.

June 30, 2022

Cancer survivors face a 42% higher risk of CVD

More aggressive CVD prevention tactics may make sense for people who have had certain types of cancer.

June 29, 2022

When Apple previewed its watchOS 9 update in early June, one of the key features the company highlighted was a new tracking option for atrial fibrillation (AFib) patients. The AFib History feature, approved for patients 22 years and older who have been diagnosed with AFib, was designed to help users gain a better understanding of their symptoms and easily share data with healthcare providers.

Regulatory Roundup: FDA clears several new solutions, including Apple’s latest AFib offering

The FDA had a busy June, clearing multiple solutions designed to treat patients with cardiovascular conditions.

June 27, 2022

. Plaque erosion detection by the proposed AI algorithm in four cases, with each column showing one case. From top to bottom are the original images, ground truth, and predicted plaque erosion by our proposed method respectively.

New AI model detects plaque erosion in arteries

Detecting plaque erosion can offer an early warning sign of restricted blood flow to the heart, which can cause heart attacks.

June 23, 2022

University of Sydney biomedical engineer Dr Arnold Lining Ju is developing a biomedical micro-device to detect these subtle platelet changes before a heart attack or stroke takes place.

New blood test could help predict upcoming heart attacks or strokes

The test works by picking up on subtle blood flow changes that are often a precursor to major medical events.

June 22, 2022

Statin use may slow progression of arterial stiffness

Continuous and high-adherent statin users had lower baseline arterial stiffness, which also grew more slowly over time.

June 21, 2022

Simpsons Interventions, a California-based healthcare technology company, has received the FDA’s breakthrough device designation for its Acolyte Image Guided Crossing and Re-Entry Catheter System. SCAI released the list of its late-breaking clinical study trials at its 2022 annual meeting. #SCAI #SCAI22 #SCAI2022

Links to all the SCAI 2022 late-breaking clinical research

The Society for Cardiovascular Angiography and Interventions (SCAI) has announced its late-breaking study presentations at its 2022 Scientific Sessions.

June 8, 2022

RAAS inhibitors lower risk of aneurysm rupture among patients with high blood pressure

Researchers also noted that uncontrolled hypertension, exposure to second-hand smoke and untreated type 2 diabetes were all associated with a greater rupture risk.

June 3, 2022

Vascular & Endovascular

Boston Scientific recalls premixed embolic agent after two deaths

Anemia may help explain why women are more likely to die during heart bypass surgery

FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices

FDA announces new recall of neurovascular catheters built by Johnson & Johnson subsidiary

GE Healthcare launching new AI software for handheld ultrasound system